CADTH Revenue and Competitors

Ottawa, ON CAN

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • CADTH's estimated annual revenue is currently $39.8M per year.(i)
  • CADTH's estimated revenue per employee is $127,500

Employee Data

  • CADTH has 312 Employees.(i)
  • CADTH grew their employee count by -2% last year.

CADTH's People

NameTitleEmail/Phone
1
Chief Scientist and VP, Scientific Evidence, Methodologies and ResourcesReveal Email/Phone
2
Communications OfficerReveal Email/Phone
3
Program Development Officer - PMDEReveal Email/Phone
4
Patient Engagement OfficerReveal Email/Phone
5
Clinical Research OfficerReveal Email/Phone
6
VP, Strategic Relationships and InitiativesReveal Email/Phone
7
Clinical Research OfficerReveal Email/Phone
8
Liaison Officer - SaskatchewanReveal Email/Phone
9
Director, Health EconomicsReveal Email/Phone
10
Director, EngagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M50%N/AN/A
#2
$60.4M47410%N/AN/A
#3
$0.7M11N/AN/AN/A
#4
$4.8M528%N/AN/A
#5
$16.2M14410%N/AN/A
#6
$25.4M2263%N/AN/A
#7
$27.9M2491%N/AN/A
#8
$30.1M2687%N/AN/A
#9
$6.4M70-4%N/AN/A
#10
$21.5M192-9%N/AN/A
Add Company

What Is CADTH?

CADTH is an independent, not-for-profit organization responsible for providing Canada’s health care decision-makers with objective evidence about drugs and medical devices.\r\n\r\nCADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.\r\n\r\nVisit our website at: www.CADTH.ca / follow us on Twitter at: @CADTH_ACMTS

keywords:N/A

N/A

Total Funding

312

Number of Employees

$39.8M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CADTH News

2022-04-19 - Treatment Trikafta Approved for Children 6 and Older in Canada

When CADTH and INESSS had reviewed Trikafta after its initial Canadian approval last year, the agencies recommended that the therapy should be...

2022-04-17 - Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 Through 11 years With At Least One F508del Mutation

-Vertex has submitted this indication to CADTH & INESSS for Health Technology Assessments-. TORONTO, April 20, 2022 /CNW/ - Vertex...

2022-03-22 - CADTH Releases Its Annual List of Health Technology Trends to ...

CADTH is an independent, not-for-profit agency funded by Canadian federal, provincial, and territorial governments (except Quebec) to provide...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M3308%N/A
#2
$74.9M333N/AN/A
#3
$108.9M343N/AN/A
#4
$115.8M343-2%N/A
#5
$64.1M3482%$49M